Resistance mediated by alternative receptor tyrosine kinases in FGFR1-amplified lung cancer.

about

Resistance mediated by alternative receptor tyrosine kinases in FGFR1-amplified lung cancer.

Item

http://www.wikidata.org/entity/Q47715159

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Resistance mediated by alterna ...... n FGFR1-amplified lung cancer.

@en

Resistance mediated by alterna ...... n FGFR1-amplified lung cancer.

@nl

type

Item

label

Resistance mediated by alterna ...... n FGFR1-amplified lung cancer.

@en

Resistance mediated by alterna ...... n FGFR1-amplified lung cancer.

@nl

prefLabel

Resistance mediated by alterna ...... n FGFR1-amplified lung cancer.

@en

Resistance mediated by alterna ...... n FGFR1-amplified lung cancer.

@nl

P1476

Resistance mediated by alterna ...... n FGFR1-amplified lung cancer.

@en

P2093

Hidenori Kitai

http://www.w3.org/2001/XMLSchema#string

Kazuyoshi Watanabe

http://www.w3.org/2001/XMLSchema#string

Kenji Kita

http://www.w3.org/2001/XMLSchema#string

Naohiko Inase

http://www.w3.org/2001/XMLSchema#string

Seiji Yano

http://www.w3.org/2001/XMLSchema#string

Yuki Sato

http://www.w3.org/2001/XMLSchema#string

Yuta Adachi

http://www.w3.org/2001/XMLSchema#string

P2860

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.

Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers.

Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.

FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.

FGFR1 amplification in lung squamous cell carcinoma: a systematic review with meta-analysis.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Fibroblast growth factor receptors, developmental corruption and malignant disease

Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer

P304

1063-1072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGX091

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hiromichi Ebi

Hiroshi Kotani

P577

2017-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28968756

http://www.w3.org/2001/XMLSchema#string